Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VSIG10L antisense RNA 1 (VSIG10L-AS1) is a long non-coding RNA that is transcribed antisense to the VSIG10L gene. There is currently no reported biological function, disease relevance, or role as a therapeutic target for this particular antisense RNA in the major scientific databases or the literature. No drugs are known to target VSIG10L-AS1, and it is not classified as a receptor, enzyme, transporter, or any canonical druggable protein class. The only available information is its identification as a non-coding RNA, with no known aliases, biological functions, or applications as a biomarker. The query may be based on mistaken identity: VSIG10L-AS1 is a non-coding antisense RNA and not a receptor, target, or protein. Its possible functional or therapeutic relevance should not be confused with the protein-coding gene VSIG10L, which does have some published relevance to disease (notably, Barrett's esophagus and esophageal adenocarcinoma). The abbreviation VSIG10L-AS1 is correct for this RNA, but it is not itself a conventional therapeutic target or receptor.
not known; no drugs target this molecule
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on VSIG10L antisense RNA 1 (VSIG10L-AS1).